Advanced Biomed is trading 11.8% down at $9.69 as the steep selloff continues following the company's abrupt cancellation of a planned securities offering.
- The stock has faced extreme volatility for over a week, recently enduring a multi-day drawdown of more than 55%.
- Investors remain cautious as the scrapped offering raises significant concerns regarding the company's future funding plans and overall risk profile.